This content is from: Portfolio Can Silicon Valley Save Abortion? New femtech startups are pushing boundaries as investors weigh the risks — and the potential rewards. By Michelle Celarier November 16, 2022
This content is from: Portfolio Medco's Prescription for Growth Medco CEO David Snow keeps the pharmacy healthy despite an ailing economy. By Claudia Deutsch May 04, 2009
This content is from: Portfolio The Morning Brief: Ackman Promises Herbalife Takedown on Tuesday By Stephen Taub July 22, 2014
This content is from: Corner Office Icahn, Soros May Revise WebMD's Prescription Carl Icahn and George Soros announce stakes in the medical information website just as analysts lower their estimates. By Stephen Taub October 26, 2011
This content is from: Portfolio Mike Pearson’s New Prescription for the Pharmaceuticals Industry Valeant Pharmaceuticals CEO Pearson’s $53 billion hostile bid to buy rival Allergan is the latest move by the former McKinsey consultant, who believes that capital is better spent on acquisitions than on R&D. By Michael Peltz September 03, 2014
This content is from: Portfolio Fed’s Latest Quantitative Easing Could Have Unpleasant Side Effects The Federal Reserve's QE2 — buying $600 billion worth of long-term Treasury bonds in the open market — is like a drug prescription that comes with a list of side effects that are often worse than the disease it is supposed to treat. By Vitaliy Katsenelson December 13, 2010
